Zobrazeno 1 - 10
of 455
pro vyhledávání: '"R. Rayner"'
Publikováno v:
IEEE Open Journal of Vehicular Technology, Vol 5, Pp 967-978 (2024)
Pedestrians are exceptionally vulnerable in road accidents, and despite the advancements in airbag technology for vehicle occupants, fatal injuries still occur due to contact between pedestrians and vehicle components. To address this issue, an innov
Externí odkaz:
https://doaj.org/article/8e1e22c40697424abce707c92a5001c1
Publikováno v:
PeerJ, Vol 10, p e14355 (2022)
The Burgersdorp Formation of South Africa is a richly fossiliferous rock sequence at the top of the Permian–Triassic Beaufort Group and is known for its abundance of Early–Middle Triassic vertebrate remains, particularly cynodonts. Fossils from t
Externí odkaz:
https://doaj.org/article/3716450395ac4408b8839b0df14aa877
Autor:
Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva, Lehana Thabane, Aline Cruz Milagres, Thiago Santiago Ferreira, Castilho Vitor Quirino dos Santos, Adhemar Dias de Figueiredo Neto, Eduardo Diniz Callegari, Leonardo Cançado Monteiro Savassi, Maria Izabel Campos Simplicio, Luciene Barra Ribeiro, Rosemary Oliveira, Ofir Harari, Holly Bailey, Jamie I Forrest, Alla Glushchenko, Sheila Sprague, Paula McKay, Craig R. Rayner, Hinda Ruton, Gordon H. Guyatt, Edward J. Mills
Publikováno v:
The Lancet Regional Health. Americas, Vol 6, Iss , Pp 100142- (2022)
Summary: Background: Observational studies have postulated a therapeutic role of metformin in treating COVID-19. We conducted an adaptive platform clinical trial to determine whether metformin is an effective treatment for high-risk patients with ear
Externí odkaz:
https://doaj.org/article/c787b7addd6647dbaccfffc94732bfc7
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 715-720 (2020)
Abstract Antivirals have demonstrated efficacy in treating other infectious diseases in early stages of disease, reducing morbidity, mortality, and the likelihood of onward transmission. At the time of writing, more than 1900 clinical trials are regi
Externí odkaz:
https://doaj.org/article/8c61aa5422a14a1782d4df8923662dec
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 5, Pp 830-834 (2020)
Externí odkaz:
https://doaj.org/article/671bf3a0425e443abe4c696b3dfe92d1
Autor:
Gilmar Reis, PhD, Eduardo Augusto dos Santos Moreira-Silva, PhD, Daniela Carla Medeiros Silva, PhD, Lehana Thabane, ProfPhD, Aline Cruz Milagres, RN, Thiago Santiago Ferreira, MD, Castilho Vitor Quirino dos Santos, Vitoria Helena de Souza Campos, Ana Maria Ribeiro Nogueira, MD, Ana Paula Figueiredo Guimaraes de Almeida, MD, Eduardo Diniz Callegari, MD, Adhemar Dias de Figueiredo Neto, PhD, Leonardo Cançado Monteiro Savassi, PhD, Maria Izabel Campos Simplicio, BScPharm, Luciene Barra Ribeiro, RN, Rosemary Oliveira, Ofir Harari, PhD, Jamie I Forrest, MPH, Hinda Ruton, MSc, Sheila Sprague, PhD, Paula McKay, MSc, Alla V Glushchenko, MD, Craig R Rayner, FRCPE, Eric J Lenze, ProfMD, Angela M Reiersen, MD, Gordon H Guyatt, ProfMD, Edward J Mills, ProfFRCP
Publikováno v:
The Lancet Global Health, Vol 10, Iss 1, Pp e42-e51 (2022)
Summary: Background: Recent evidence indicates a potential therapeutic role of fluvoxamine for COVID-19. In the TOGETHER trial for acutely symptomatic patients with COVID-19, we aimed to assess the efficacy of fluvoxamine versus placebo in preventing
Externí odkaz:
https://doaj.org/article/a0e3d44df2b844c5a67fa94c2b64b787
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 4, Pp 646-648 (2020)
The global response to finding therapeutics for coronavirus disease 2019 (COVID‐19) is chaotic even if well intentioned. There is an opportunity, but more importantly, an obligation for the global clinical and quantitative pharmacology community to
Externí odkaz:
https://doaj.org/article/5b16b0e90d9a48b9b6b359ff909525e7
Autor:
Gilmar Reis, Eduardo A.S. Moreira Silva, Daniela C. Medeiros Silva, Lehana Thabane, Vitoria H.S. Campos, Thiago S. Ferreira, Castilho V.Q. Santos, Ana M.R. Nogueira, Ana P.F.G. Almeida, Leonardo C.M. Savassi, Adhemar D. Figueiredo-Neto, Ana C.F. Dias, Adelino M. Freire Júnior, Carina Bitarães, Aline C. Milagres, Eduardo D. Callegari, Maria I.C. Simplicio, Luciene B. Ribeiro, Rosemary Oliveira, Ofir Harari, Lindsay A. Wilson, Jamie I. Forrest, Hinda Ruton, Sheila Sprague, Paula McKay, Christina M. Guo, Eve H. Limbrick-Oldfield, Steve Kanters, Gordon H. Guyatt, Craig R. Rayner, Christopher Kandel, Mia J. Biondi, Robert Kozak, Bettina Hansen, M. Atif Zahoor, Paul Arora, Colin Hislop, Ingrid Choong, Jordan J. Feld, Edward J. Mills, Jeffrey S. Glenn
Publikováno v:
New England Journal of Medicine, 388(6), 518-528. Massachussetts Medical Society
Background: The efficacy of a single dose of pegylated interferon lambda in preventing clinical events among outpatients with acute symptomatic coronavirus disease 2019 (Covid-19) is unclear. Methods: We conducted a randomized, controlled, adaptive p
Autor:
M.J. Tsai, R. Rayner, L. Chafin, D. Farkas, J. Adair, R.K. Mallampalli, S. Kim, E. Cormet-Boyaka, J.D. Londino
Publikováno v:
A29. EPITHELIUM: FIRST LINE OF DEFENSE.
Autor:
Edward J Mills, Jason A. Roberts, Alex Lepak, Debra Hanna, Mark J. Shelton, Kayla Ann Andrews, Craig R. Rayner, Lena E. Friberg, Patrick F. Smith, David Wesche, David R. Andes, Karen Rowland‐Yeo, Hartmut Derendorf, Virna J A Schuck, Thomas M. Polasek
Publikováno v:
Clinical Pharmacology and Therapeutics
Model-informed drug development (MIDD) has a long and rich history in infectious diseases. This review describes foundational principles of translational anti-infective pharmacology, including choice of appropriate measures of exposure and pharmacody